Camden National director receives 279-share stock award

Camden National Corp director Raina Maxwell reported an equity grant of common stock.

Rhea-AI Filing Summary

Camden National Corp director Raina Maxwell reported an equity grant of common stock. Maxwell acquired 279 shares of Camden National Corp common stock on June 18, 2026 at a reference value of $51.49 per share. The shares were issued under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees, meaning this was a compensation-related award rather than an open-market purchase. Following this grant, Maxwell directly holds 4,032.818 shares of Camden National Corp common stock.

Insider Trade Summary

Grant/Award: 279 shares

Grant/Award 1 txn

Insider Maxwell Raina

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	279	$51.49	$14K

Holdings After Transaction: Common Stock — 4,032.818 shares (Direct)

Footnotes (1)

1. F1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Key Figures

Shares granted: 279 shares Grant reference price: $51.49 per share Total shares after grant: 4,032.818 shares

3 metrics

Shares granted 279 shares Equity award in lieu of director fees on June 18, 2026

Grant reference price $51.49 per share Reference value for the 279-share grant

Total shares after grant 4,032.818 shares Director’s direct holdings following the transaction

Key Terms

2022 Equity and Incentive Plan, Grant, award, or other acquisition, in lieu of director fees

3 terms

2022 Equity and Incentive Plan financial

"Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

in lieu of director fees financial

"Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Camden National Corp (CAC) report for Raina Maxwell?

Camden National Corp reported that director Raina Maxwell received 279 shares of common stock. The shares were granted as compensation under the 2022 Equity and Incentive Plan in lieu of director fees, not bought on the open market.

Was Raina Maxwell’s Camden National (CAC) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a stock grant, not a purchase. Code “A” indicates a grant, award, or other acquisition, and a footnote clarifies the 279 shares were issued under the 2022 Equity and Incentive Plan in lieu of director fees.

How many Camden National Corp (CAC) shares does Raina Maxwell own after this Form 4?

After the reported grant, Raina Maxwell directly holds 4,032.818 Camden National Corp common shares. This total includes the 279-share equity award received on June 18, 2026 as compensation for board service.

What price per share is referenced in Raina Maxwell’s Camden National (CAC) stock grant?

The grant references a value of $51.49 per share for the 279 Camden National Corp common shares. This price is typically a reporting value for the award and does not represent an open-market trade execution price.

Under which plan were Raina Maxwell’s Camden National (CAC) shares granted?

The 279 shares were granted under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment. A footnote explains they were issued in lieu of director fees, reflecting standard equity-based director compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 01:40 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maxwell Raina

(Last) (First) (Middle)

2 ELM STREET

P.O. BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2026		A		279(1)	A	$51.49	4,032.818	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Remarks:

	Christopher G. Hutchinson, POA	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)